Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: Phenotypic and mutational spectrum

Journal of the Neurological Sciences

Volumn 203-204, Issue , 2002, Pages 77-80

  Dichgans, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CADASIL; Cerebrovascular disease; Dementia; Notch3; Small vessel disease; Stroke

Indexed keywords

NOTCH RECEPTOR; NOTCH3 RECEPTOR; UNCLASSIFIED DRUG;

BRAIN BLOOD FLOW; CADASIL; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; HUMAN; MISSENSE MUTATION; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; STROKE; VASCULAR SMOOTH MUSCLE;

COGNITION DISORDERS; DEMENTIA, MULTI-INFARCT; DISEASE PROGRESSION; HUMANS; MIGRAINE DISORDERS; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH;

EID: 0037111353     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00270-8     Document Type: Conference Paper

References (37)

1. Dichgans M., Mayer M., Uttner I., Bruning R., Muller-Hocker J., Rungger G.et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann. Neurol. 44:1998;731-739.
2. Chabriat H., Vahedi K., Iba-Zizen M.T., Joutel A., Nibbio A., Nagy T.G.et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 346:1995;934-939.
3. Desmond D.W., Moroney J.T., Lynch T., Chan S., Chin S.S., Mohr J.P. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 30:1999;1230-1233.
4. Rubio A., Rifkin D., Powers J.M., Patel U., Stewart J., Faust P.et al. Phenotypic variability of CADASIL and novel morphologic findings. Acta Neuropathol. (Berl.). 94:1997;247-254.
5. Dichgans M., Filippi M., Bruning R., Iannucci G., Berchtenbreiter C., Minicucci L.et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology. 52:1999;1361-1367.
6. Chabriat H., Pappata S., Poupon C., Clark C.A., Vahedi K., Poupon F.et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke. 30:1999;2637-2643.
7. Iannucci G., Dichgans M., Rovaris M., Brüning R., Gasser T., Giacomotti L.et al. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 32:2001;643-648.
8. Lagas P.A., Juvonen V. Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Nord. J. Psychiatry. 55:2001;41-42.
9. Hutchinson M., O'Riordan J., Javed M., Quin E., Macerlaine D., Wilcox T.et al. Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). Ann. Neurol. 38:1995;817-824.
10. Gutierrez-Molina M., Caminero R.A., Martinez G.C., Arpa G.J., Morales B.C., Amer G. Small arterial granular degeneration in familial Binswanger's syndrome. Acta Neuropathol. (Berl.). 87:1994;98-105.
11. Baudrimont M., Dubas F., Joutel A., Tournier-Lasserve E., Bousser M.G. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke. 24:1993;122-125.
12. Feuerhake F., Volk B., Ostertag B., Jungling D., Kassubek J., Orszagh M.et al. Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol. (Berl.). 103:2002;188-192.
13. Dichgans M., Wick M., Gasser T. Cerebrospinal fluid findings in CADASIL. Neurology. 53:1999;233.
14. Caplan L.R. Binswanger's disease - revisited. Neurology. 45:1995;626-633.
15. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P.et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 383:1996;707-710.
16. Weinmaster G. The ins and outs of notch signaling. Mol. Cell Neurosci. 9:1997;91-102.
17. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science. 284:1999;770-776.
18. Joutel A., Vahedi K., Corpechot C., Troesch A., Chabriat H., Vayssiere C.et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 350:1997;1511-1515.
19. Dichgans M., Ludwig H., Müller-Höcker J., Messerschmidt A., Gasser T. Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur. J. Hum. Genet. 8:2000;280-285.
20. Dichgans M., Herzog J., Gasser T. Notch3 in-frame deletion involving three cysteine residues causes typical CADASIL. Neurology. 57:2001;1714-1717.
21. Joutel A., Andreux F., Gaulis S., Domenga V., Cecillon M., Battail N.et al. The ectodomain of Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105:2000;597-605.
22. Ruchoux M.M., Guerouaou D., Vandenhaute B., Pruvo J.P., Vermersch P., Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. (Berl.). 89:1995;500-512.
23. Wang W., Prince C., Mou Y., Pollman M.J. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation: resistance to FasL-induced apoptosis. J. Biol. Chem. 2002.
24. Chabriat H., Bousser M.G., Pappata S. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a positron emission tomography study in two affected family members. Stroke. 26:1995;1729-1730.
25. Chabriat H., Pappata S., Ostergaard L., Clark C.A., Pachot-Clouard M., Vahedi K.et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke. 31:2000;1904-1912.
26. 2 reactivity in CADASIL: a transcranial doppler sonography study. Stroke. 32:2001;17-21.
27. Brüning R., Dichgans M., Berchtenbreiter C., Yousry T.A., Seelos K., Wu R.H.et al. CADASIL: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance. AJNR, Am. J. Neuroradiol. 22:2001;1268-1274.
28. Mellies J.K., Baumer T., Muller J.A., Tournier-Lasserve E., Chabriat H., Knobloch O.et al. SPECT study of a German CADASIL family: a phenotype with migraine and progressive dementia only. Neurology. 50:1998;1715-1721.
29. Liebetrau M., Herzog J., Hamann G., Dichgans M. Prolonged cerebral transit time in CADASIL: a transcranial ultrasound study. Stroke. 33:2002;509-512.
30. Terborg C., Gora F., Weiller C., Rother J. Reduced vasomotor reactivity in cerebral microangiopathy: a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke. 31:2000;924-929.
31. Molina C., Sabin J.A., Montaner J., Rovira A., Abilleira S., Codina A. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: a case-control study. Stroke. 30:1999;2296-2301.
32. Forteza A.M., Brozman B., Rabinstein A.A., Romano J.G., Bradley W.G. Acetazolamide for the treatment of migraine with aura in CADASIL. Neurology. 57:2001;2144-2145.
33. Dichgans M., Holtmannspötter K., Herzog J., Peters N., Bergmann M., Yousry T.A. Cerebral microbleeds in CADASIL: a gradient-echo MRI and autopsy study. Stroke. 33:2002;67-71.
34. Oberstein S.A., Ferrari M.D., Bakker E., van Gestel J., Kneppers A.L., Frants R.R.et al. Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research Group. Neurology. 52:1999;1913-1915.
35. Joutel A., Chabriat H., Vahedi K., Domenga V., Vayssiere C., Ruchoux M.M.et al. Splice site mutation causing a 7 amino-acids Notch3 in frame deletion in CADASIL. Neurology. 54:2000;1874-1875.
36. Lesnik Oberstein S.A., van den B.R., Van Buchem M.A., van Houwelingen H.C., Bakker E., Vollebregt E.et al. Cerebral microbleeds in CADASIL. Neurology. 57:2001;1066-1070.
37. Tuominen S., Juvonen V., Amberla K., Jolma T., Rinne J.O., Tuisku S.et al. Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation. Stroke. 32:2001;1767-1774.